Differential modulation of the expression of important drug metabolising enzymes and transporters by endothelin-1 receptor antagonists ambrisentan and bosentan in vitro.
about
Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomicsRifampicin alters the expression of reference genes used to normalize real-time quantitative RT-PCR data.Venetoclax (ABT-199) Might Act as a Perpetrator in Pharmacokinetic Drug-Drug Interactions.Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteers.Current understanding of hepatic and intestinal OATP-mediated drug-drug interactions.Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs.Impact of enzalutamide and its main metabolite N-desmethyl enzalutamide on pharmacokinetically important drug metabolizing enzymes and drug transporters.Obatoclax as a perpetrator in drug-drug interactions and its efficacy in multidrug resistance cell lines.Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro.In-vitro evaluation of chronic alcohol effects on expression of drug-metabolizing and drug-transporting proteins.Interaction potential of the endothelin-A receptor antagonist atrasentan with drug transporters and drug-metabolising enzymes assessed in vitro.Interaction potential of the multitargeted receptor tyrosine kinase inhibitor dovitinib with drug transporters and drug metabolising enzymes assessed in vitro.Association of liver stiffness with hepatic expression of pharmacokinetically important genes in alcoholic liver disease.
P2860
Q34344390-90171FD3-BA11-4F03-A22E-34C173A13BA4Q34349015-73E5CAE0-7696-40E9-B79E-AB28E54B74C4Q36735325-9B340E29-1E46-44EF-BBE4-D19489FEB3EFQ37492042-871BCEE8-7721-47C7-B07E-92991173EDE0Q37960129-B3A07AED-7FBB-4F04-8AB0-3D5236161247Q37962449-C25B063D-4E67-4880-BCBC-EE6C36210A32Q38597025-93D0C630-B27E-4A93-941D-50F0E6BC6C23Q38845179-AF090278-5144-402A-9BF0-E176AA437279Q38925278-6DB57623-8749-4AFB-BFB1-3552014D33EAQ39096762-8D325B22-FCC3-4467-AF72-7E30BF748273Q39497283-6E63FEA3-F803-4A31-9546-7CBAF54BDF6EQ43084566-01F2C4AC-37B5-475F-94D4-70F8338E2389Q43867191-72275DBD-7A67-48C8-86B2-B2227A44A0AC
P2860
Differential modulation of the expression of important drug metabolising enzymes and transporters by endothelin-1 receptor antagonists ambrisentan and bosentan in vitro.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Differential modulation of the ...... isentan and bosentan in vitro.
@en
Differential modulation of the ...... isentan and bosentan in vitro.
@nl
type
label
Differential modulation of the ...... isentan and bosentan in vitro.
@en
Differential modulation of the ...... isentan and bosentan in vitro.
@nl
prefLabel
Differential modulation of the ...... isentan and bosentan in vitro.
@en
Differential modulation of the ...... isentan and bosentan in vitro.
@nl
P1476
Differential modulation of the ...... isentan and bosentan in vitro.
@en
P2093
Johanna Weiss
Melanie Herzog
P304
P356
10.1016/J.EJPHAR.2011.04.003
P407
P577
2011-04-09T00:00:00Z